71:
53:
22:
139:
180:
149:
228:
are where people discuss how to make content on
Knowledge (XXG) the best that it can be. You can use this page to start a discussion with others about how to improve the "
260:
111:
117:
265:
174:
87:
255:
78:
58:
225:
193:
33:
39:
21:
86:
on
Knowledge (XXG). If you would like to participate, please visit the project page, where you can join
243:
208:
188:
236:
154:
249:
70:
52:
83:
229:
202:
169:
138:
147:
for
Knowledge (XXG)'s health content are defined in the guideline
133:
15:
150:
Knowledge (XXG):Identifying reliable sources (medicine)
221:
Start a discussion about improving the
Oxelumab page
82:, a collaborative effort to improve the coverage of
194:
clinical publications about evidence-based medicine
116:This article has not yet received a rating on the
8:
47:
19:
261:Unknown-importance pharmacology articles
175:review articles from the past five years
96:Knowledge (XXG):WikiProject Pharmacology
49:
7:
203:Centre for Reviews and Dissemination
76:This article is within the scope of
38:It is of interest to the following
14:
266:WikiProject Pharmacology articles
200:Other potential sources include:
99:Template:WikiProject Pharmacology
256:Stub-Class pharmacology articles
137:
69:
51:
20:
1:
161:sources of information about
90:and see a list of open tasks.
282:
118:project's importance scale
115:
64:
46:
79:WikiProject Pharmacology
28:This article is rated
102:pharmacology articles
32:on Knowledge (XXG)'s
181:free review articles
157:. Here are links to
238:Start a discussion
153:and are typically
34:content assessment
217:
216:
132:
131:
128:
127:
124:
123:
273:
241:
239:
141:
134:
104:
103:
100:
97:
94:
73:
66:
65:
55:
48:
31:
25:
24:
16:
281:
280:
276:
275:
274:
272:
271:
270:
246:
245:
244:
242:
237:
235:
234:
159:possibly useful
155:review articles
101:
98:
95:
92:
91:
29:
12:
11:
5:
279:
277:
269:
268:
263:
258:
248:
247:
223:
222:
219:
218:
215:
214:
213:
212:
198:
185:
166:
142:
130:
129:
126:
125:
122:
121:
114:
108:
107:
105:
88:the discussion
74:
62:
61:
56:
44:
43:
37:
26:
13:
10:
9:
6:
4:
3:
2:
278:
267:
264:
262:
259:
257:
254:
253:
251:
240:
233:
231:
227:
220:
211:
210:
205:
204:
199:
196:
195:
190:
189:TRIP database
186:
183:
182:
177:
176:
171:
168:
167:
164:
160:
156:
152:
151:
146:
145:Ideal sources
143:
140:
136:
135:
119:
113:
110:
109:
106:
89:
85:
81:
80:
75:
72:
68:
67:
63:
60:
57:
54:
50:
45:
41:
35:
27:
23:
18:
17:
224:
207:
201:
192:
179:
173:
162:
158:
148:
144:
93:Pharmacology
84:Pharmacology
77:
59:Pharmacology
40:WikiProjects
250:Categories
226:Talk pages
178:(limit to
30:Stub-class
191:provides
172:provides
232:" page.
230:Oxelumab
163:Oxelumab
170:PubMed
36:scale.
206:and
187:The
209:CDC
112:???
252::
197:.
184:)
165:.
120:.
42::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
